Bayer HealthCare acquires Teva Pharmaceutical Industries’ U.S. animal health business

January 7, 2013

The acquisition, which was announced in September 2012, met all requirements contained in the initial agreement between Bayer and Teva, and recently received the necessary regulatory approval from the Federal Trade Commission.

“This acquisition fits nicely with our strategic goals. It allows us to strengthen and broaden our range of animal care solutions in the U.S. market,” said Joerg Reinhardt, CEO, Bayer HealthCare.

Bayer HealthCare Animal Health’s food animal franchise will be strengthened with the addition of a range of anti-infective solutions to treat infections in livestock populations. It also introduces reproductive hormones such as Prostamate and Ovacyst to Bayer’s product offerings.

Bayer’s growing companion animal business is further enriched with the addition of dermatological, pet wellness and nutraceutical products.

—From Bayer HealthCare news release

BUYER'S GUIDE

VISIT OUR BUYER’S GUIDE

We build sustainable growth for beef seedstock businesses and their ranch customers through brand development, collaborative economies of scale, simplification of emerging technology simplification of emerging technology, genetic selection tools a...

We provide high quality agricultural products that provide excellent forage protection, helping your hay and silage hold value until it is needed.

Quality Liquid Feeds is a nationwide, innovative leader in the developing and manufacturing of liquid feed supplements, cooked low moisture blocks and liquid carbon based fertilizers.